How bad can it get? Bounding worst case endemic heterogeneous mixing models of HIV/AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


How bad can it get? Bounding worst case endemic heterogeneous mixing models of HIV/AIDS.

Math Biosci. 1990 May;99(2):157-80. Unique Identifier : AIDSLINE MED/92199727
Kaplan EH; Lee YS; Operations Research Department, Yale University, New Haven,; Connecticut 06520.

Abstract: Simple models of HIV transmission assume random (proportionate) mixing among subpopulations with differing sexual activity rates, while more complex models assume some form of nonrandom heterogeneous mixing. Since the modeled number of persons infected with HIV does depend upon the specific mixing assumptions employed, it is natural to consider the maximum number of infections that could occur under any feasible mixing pattern. Such worst case results are of special interest to decision makers who must prospectively evaluate the consequences of planned public health interventions. This paper derives upper bounds for the maximum number of infected persons possible under endemic steady state conditions within the workings of a heterogeneous mixing model of HIV transmission. We present two examples that utilize this bound for a range of parameter values reasonably descriptive of HIV/AIDS. These examples, summarized in Figures 4 and 5, show that the worst case number of infected persons in the endemic steady state can be well within 10% of the number of infected persons that would result from random mixing.
Keywords: Disease Outbreaks Human HIV Infections/EPIDEMIOLOGY/*TRANSMISSION Male Mathematics Models, Biological Sex Behavior JOURNAL ARTICLEKWDdiseaseoutbreakshumanhivinfections/epidemiology/KWDtransmissionmalemathematicsmodels,biologicalsexbehaviorjournalarticle
920730
M9271081

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .